SARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and Memantine.
In conclusion, as a route to curb viral virulence and abate COVID-19, we point to the E protein of SARS-CoV-2 as an attractive drug target and identify off-label compounds that inhibit it.
PMID: 32828269 [PubMed - as supplied by publisher]
Source: Biochemical and Biophysical Research communications - Category: Biochemistry Authors: Singh Tomar PP, Arkin IT Tags: Biochem Biophys Res Commun Source Type: research
More News: Biochemistry | Coronavirus | COVID-19 | Databases & Libraries | Namenda | Pandemics | SARS